Sort   by:  
 Page size 
UnknownColon cancer subtypes: concordance, effect on survival and selection of the most representative preclinical models.
Not available
S-EPMC5111107 | biostudies-literature
UnknownA comprehensive overview of targeted therapy in metastatic renal cell carcinoma.
Not available
S-EPMC3434473 | biostudies-literature
UnknownIntratumoral T-cell and B-cell receptor architecture associates with distinct immune tumor microenvironment features and clinical outcomes of anti-PD-1/L1 immunotherapy.
Not available
S-EPMC10445359 | biostudies-literature
UnknownValidation of RNAi Silencing Efficiency Using Gene Array Data shows 18.5% Failure Rate across 429 Independent Experiments.
Not available
S-EPMC5056990 | biostudies-literature
UnknownDynamic classification using case-specific training cohorts outperforms static gene expression signatures in breast cancer.
Not available
S-EPMC4354298 | biostudies-literature
UnknownHistopathology and proteomics are synergistic for High-Grade Serous Ovarian Cancer platinum response prediction.
Not available
S-EPMC11177907 | biostudies-literature
UnknownA major genetic accelerator of cancer diagnosis: rs867228 in FPR1.
Not available
S-EPMC7801119 | biostudies-literature
UnknownHistopathology and proteomics are synergistic for high-grade serous ovarian cancer platinum response prediction.
Not available
S-EPMC11762732 | biostudies-literature
UnknownPALB2 or BARD1 loss confers homologous recombination deficiency and PARP inhibitor sensitivity in prostate cancer.
Not available
S-EPMC9242979 | biostudies-literature
UnknownA loss-of-function polymorphism in ATG16L1 compromises therapeutic outcome in head and neck carcinoma patients.
Not available
S-EPMC9037530 | biostudies-literature
Sort   by:  
 Page size